Federal contract award
75A50125C00018
THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN44 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $12.0M |
| Current contract value | $12.0M |
| Potential contract value / ceiling | $147.7M |
| Start date | Sep 29, 2025 |
| Current end date | Dec 31, 2028 |
| Potential end date | Jun 30, 2036 |
| Latest award activity | Aug 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 10, 2026 | P00001 | $230.3K | THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA |
| Sep 30, 2025 | 0 | $11.8M | THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA |
Estimated positioning window
Jun 30, 2035 – Dec 30, 2035
40/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 40/100. Available recorded signals: 35 points.
- Contract end 2036-06-30 (3529 days from calculation)
- +5 points
- 2 historical awards in this buyer and category group
- +10 points
- 2 recorded award transactions
- +5 points
- Latest award action: 2026-08-10
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 20, 2026 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 19, 2026 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | May 29, 2025 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Dec 18, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | May 31, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Apr 23, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Mar 29, 2024 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Dec 22, 2023 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Nov 9, 2023 |
| BARDA-BAA@hhs.gov | Contact | BARDA-BAA@hhs.gov | Source | Sep 26, 2023 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.